<DOC>
	<DOCNO>NCT00244608</DOCNO>
	<brief_summary>The purpose study determine flexible dose Symbicort similar effect airways patient asthma high fixed-dose Symbicort additional glucocorticosteroids add .</brief_summary>
	<brief_title>A Comparison Control Asthma Provided Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Diagnosis asthma least 6 month Prescribed daily use glucocorticosteroids least 3 month prior visit one Respiratory infection affect asthma within 30 day prior study Intake oral , rectal , parenteral glucocorticosteroids within 30 day prior study Any significant disease disorder may jeopardize safety patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>